InvestorsHub Logo
Followers 3
Posts 253
Boards Moderated 0
Alias Born 08/23/2007

Re: jhnvtjll post# 8851

Monday, 07/09/2018 7:03:19 AM

Monday, July 09, 2018 7:03:19 AM

Post# of 9747
NO, Great News

Soligenix Receives European and Canadian Patents for its Ricin Toxin Vaccine (RiVax®) Formulation

As a biodefense vaccine, RiVax® also has the potential to qualify for a priority review voucher (PRV) upon FDA approval. Recent PRVs have sold for as much $350 million.

https://finance.yahoo.com/news/soligenix-receives-european-canadian-patents-100000144.html

GO SNGX
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News